Narmada Gelatines Ltd Valuation Shifts Signal Attractive Investment Opportunity

Valuation Metrics Reflect Enhanced Price Attractiveness

The company’s price-to-earnings (P/E) ratio currently stands at 9.21, a notable decrease from the peer average of 10.19 and substantially lower than many competitors in the specialty chemicals sector. For context, Stallion India and Sanstar trade at P/E multiples of 49.6 and 60.15 respectively, while Titan Biotech and I G Petrochems command even more elevated valuations exceeding 60 and 600 times earnings. This compression in Narmada Gelatines’ P/E ratio highlights a more reasonable price relative to earnings, enhancing its appeal to value-conscious investors.

Similarly, the price-to-book value (P/BV) ratio of 2.05 remains moderate, reflecting a balanced valuation relative to the company’s net asset base. This contrasts with the sector’s more expensive players, where P/BV ratios often exceed 10, indicating that Narmada Gelatines is trading at a discount to its intrinsic book value compared to peers.

Enterprise value to EBITDA (EV/EBITDA) at 7.20 further underscores the company’s attractive valuation. This metric is significantly lower than the sector heavyweights such as Sanstar (51.28) and Titan Biotech (46.55), suggesting that Narmada Gelatines offers a more cost-effective entry point relative to its operational cash flow generation.

Strong Financial Performance Supports Valuation

Beyond valuation, Narmada Gelatines boasts impressive profitability metrics. The return on capital employed (ROCE) is a robust 25.78%, while return on equity (ROE) stands at 20.13%. These figures indicate efficient capital utilisation and strong shareholder returns, reinforcing the company’s quality credentials. The dividend yield of 2.09% adds an income component to the investment case, attractive in a micro-cap specialty chemicals stock.

Moreover, the company’s PEG ratio of 0.16 suggests that earnings growth is not fully priced in, offering potential upside as growth materialises. This low PEG ratio contrasts sharply with peers like Titan Biotech, which has a PEG of 1.55, indicating that Narmada Gelatines may be undervalued relative to its growth prospects.

Market Performance Outpaces Benchmarks

Examining returns over various periods reveals Narmada Gelatines’ strong market performance. Year-to-date, the stock has surged 39.33%, vastly outperforming the Sensex’s decline of 13.26%. Over one year, the stock gained 20.59% compared to the Sensex’s 10.34% loss, and over five years, the stock’s return of 179.06% dwarfs the Sensex’s 42.31%. Even on a decade-long horizon, the stock’s 270.08% return comfortably exceeds the benchmark’s 176.19%.

Such consistent outperformance, coupled with the recent valuation grade upgrade from fair to attractive on 25 May 2026, signals growing investor confidence and a favourable risk-reward profile.

Comparative Analysis Highlights Relative Value

When benchmarked against its peers in the specialty chemicals sector, Narmada Gelatines emerges as one of the most attractively valued stocks. While companies like Stallion India, Sanstar, and Titan Biotech are classified as very expensive with P/E ratios above 49 and EV/EBITDA multiples exceeding 30, Narmada Gelatines’ valuation metrics remain modest. This disparity suggests that the market has yet to fully recognise the company’s growth and profitability potential.

Notably, TGV Sraac is the only peer with a more attractive valuation, sporting a P/E of 8.87 and EV/EBITDA of 3.91, but it is important to consider Narmada Gelatines’ superior return ratios and dividend yield in the overall assessment.

Price Movement and Trading Range

The stock’s current price of ₹481.10 is close to its 52-week high of ₹530.00, reflecting positive market sentiment. The recent day’s trading range between ₹477.35 and ₹487.80, with a modest day change of 0.46%, indicates steady investor interest without excessive volatility. The 52-week low of ₹327.30 provides a significant cushion, underscoring the stock’s resilience and potential for further appreciation.

Outlook and Investment Considerations

Given the upgrade in valuation grade to attractive and a strong Mojo Score of 84.0 with a corresponding Mojo Grade of Strong Buy (upgraded from Buy on 25 May 2026), Narmada Gelatines is positioned favourably for investors seeking quality micro-cap exposure in the specialty chemicals sector. The company’s combination of reasonable valuation, robust profitability, and consistent market outperformance presents a compelling investment case.

Investors should, however, remain mindful of the micro-cap nature of the stock, which can entail higher volatility and liquidity considerations. Nonetheless, the company’s strong fundamentals and valuation discount relative to peers provide a margin of safety.

Conclusion: A Rare Valuation Opportunity in Specialty Chemicals

Narmada Gelatines Ltd’s recent valuation upgrade from fair to attractive, combined with its strong financial metrics and consistent market outperformance, marks it as a standout opportunity within the specialty chemicals sector. The company’s P/E ratio of 9.21 and EV/EBITDA of 7.20 are well below sector averages, signalling undervaluation relative to earnings and cash flow generation.

With a robust ROCE of 25.78% and ROE of 20.13%, alongside a healthy dividend yield, the stock offers both growth and income potential. Its micro-cap status and strong Mojo Grade of Strong Buy further reinforce the positive outlook.

Investors seeking exposure to a fundamentally sound, attractively priced specialty chemicals company would do well to consider Narmada Gelatines as part of their portfolio strategy.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →